32
Views
14
CrossRef citations to date
0
Altmetric
Research Article

Anti VLA-4 monoclonal antibody inhibits eosinophil infiltration in allergic conjunctivitis model of guinea pig

, , , , , & show all
Pages 20-25 | Published online: 02 Jul 2009

References

  • Buckley RJ. Vernal keratoconjunctivitis. Int Ophthalmol Clin. 1988;28:303–308.
  • Smolin G, O'Connor GR. Ocular Immunology, 2nd ed. Boston, Little, Brown, 1986;135–192.
  • Trantas A. Sur le catarrhe printanier. Arch Ophthalmol (Fr). 1910;30:593–621.
  • Udell IJ, Gleich GJ, Allansmith MR, Ackerman SJ, Abelson MB. Eosinophil granule major basic protein and charcot-leyden crystal protein in human tears. Am J Ophthalmol. 1981;92:824–828.
  • Trocme SD, Kephart GM, Allansmith MR, Bourne WM, Gleich GJ. Eosinophil granule major basic protein in vernal keratoconjunctivitis and contact lens - associated giant papillary conjunctivitis. Am J Ophthalmol. 1989;108:57–63.
  • Trocme SD, Kephart GM, Bourne WN, Buckley RJ, Gleich GJ. Eosinophil granule major basic protein depo-sition in corneal ulcers associated with vernal kerato-conjunctivitis. Am J Ophthalmol. 1993;115:640–643.
  • Trocme SD, Gleich GJ, Zieske JD. Eosinophil granule major basic protein inhibition of corneal epithelial wound healing in vitro. Invest Ophthalmol Vis Sci. 1994;35:3051–3056.
  • Trocme SD, Hallbarg CK, Gill KS, Gleich GJ, Tyring SK, Brysk MM. Effects of eosinophil granule proteins on human corneal epithelial cell viability and morphol-ogy. Invest Ophthalmol Vis Sci. 1997;38:593–599.
  • Resnik MB, Weller PF. Mechanisms of Eosinophil Re-cruitment. Am J Respir Cell Mol Biol 1993;8:349–355.
  • Wardlaw AJ, Walsh GM, Symon FA. Mechanisms of eosinophil and basophil migration. Allergy. 1994;49:797–807.
  • Weg VB, Williams JJ, Lobb RR, Noursharghs. A mono-clonal antibody recognizing the very late activation an-tigen-4 inhibits eosinophil accumulation in vivo. J Exp Med. 1993;177:561–566.
  • Sagara H, Matsuda H, Yagita H, Fukuda T, Okumura K, Makino S, Ra C. A monoclonal antibody against very late activation antigen -4 (VLA-4) inhibits eosinophil accumulation and late athematic response in guinea pig model of athema. Int Arch Allergy Immunol. 1997;112: 287–290.
  • Metzger WJ, Ridgr V, Tollefson V, Arrhenius T, Gaeta FCA, Elices M. Anti-VLA-4 antibody and CS-I peptide inhibitor modify airway inflammation and bronchial air-way hyperresponsiveness (BHR) in the allergic rabbit. J Allergy Clin Immunol. 1993;91:822. (abstract)
  • Porter DP, Trocme SD, Foster CS, Dohlman CH. Conjuncitval deposition of eosinophil major basic pro-tein, neutrophil elastase, and mast cell tryptase in atopic keratoconjunctivitis. Invest Ophthalmol Vis Sci. 1993;34(suppl):855. (abstract)
  • Trocme SD, Aldave AJ. The eye and the eosinophil. Survey of Ophthalmol. 1994;39:241–252.
  • Butcher EC. Leukocyte-endothelial cell recognition: Three (or More) steps to specificity and diversity. Cell. 1991;67:1033–1036.
  • Zimmerman GA, Prescott SM, McIntyre TM. Endothe-lial cell interactions with granulocytes:tethering and sig-naling molecules. Immunology Today. 1992;13:93–100.
  • Henriquez AS, Kenyon KR, Allansmith MR. Mast cell ultrastructure. Arch Ophthalmol. 1981;99:1266–1272.
  • Gordon JR, Burd PR, Galli SJ. Mast cells as a source of multifunctional cytokines. Immunology Today. 1990;11:458–464.
  • Burd PR, Thompson WC, Max EE, Mills FC. Activated mast cells produce interleukin-13. J Exp Med. 1995;181:1373–1380.
  • Bradding P, Feather IH, Howarth R, Mueller R, Roberts JA, Britten K, Bews JPA, Hunt TC, Okayama Y, Heusser CH, Bullock GR, Church MK, Holgate ST. Interleukin4 is localized to and released by human mast cells. J Exp Med. 1992;176: 1381–1386.
  • Bradding P, Feather IH, Wilson S, Bardin PG, Heusser CH, Holgate ST, Howarth PH. Immunolocalization of cytokines in the nasal mucosa of normal and perennial rhinitic subjects. The mast cell as a source of IL-4, IL-5 and IL-6 in human allergic mucosal inflammation. J Immunol. 1993;151: 3853–3865.
  • Bradding P, Roberts JA, Britten KM, Montefort S, Djukanovic R, Mueller R, Heusser CH, Howarth PH, Holgate ST. Interleukin-4. 5, and 6 and tumor necrosis factor a in normal and asthmatic airways:evidence for the human mast cell as a source of these cytokines. Am J Respir Cell Mol Biol. 1994;10: 471–480.
  • Dobrina A, Menegazzi R, Carlos TM, Nardon E, Cramer R, Zacchi T, Harlan JM, Patiriarca P. Mechanisms of eosinophil adherence to cultured vascular endothelial cells. J Clin Invest. 1991;88:20–26.
  • Weller PF, Rand TH, Goelz SE, Rosso GH, Lobb RP. Human eosinophil adherence to vascular endothelium mediated by binding to vascular cell adhesion molecule and endothelial leukocyte adhesion molecule. Proc Narl Acad Sci USA. 1991;88:7430–7433
  • Ebisawa M, Bochner BS, Georos SN, Schleimer RP. Eosinophil transendothelial migration induced by cytokines. J Immunol. 1992;149:4021–4028.
  • Schleimer RP, Sterbinsky SA, Kaiser J, Bickel CA, Munk DA, Tomioka K, Newman W, Luscinskas FW, Gimbrone JR MA, Mcintyre BW, Bochner BS. IL-4 induces ad-herence of human eosinophils and basophils but not neutrophils to endothelium. J Immunol. 1992; 148:1086–1092.
  • Bochner BS, Munk DA, Sterbinski SA, Coffman RL, Schleimer RP. IL-13 selectively induces vascular cell adhesion molecule-1 expression in human endothelial cells. J Immunol. 1995;154: 799–803.
  • Elices MJ, Osborn L, Takada Y, Crouse C, Luhowskyi S, Hemler ME, Lobb RR. VCAM-1 on activated endot-helium interacts with the leukocyte integrin VLA-4 at a site distinct from the VLA-4/ fibronectin binding site. Cell. 1990;60: 577–584.
  • Ebihara N, Kimura T, Santo RM, Yokoyama T, Kanai A, Abe H. The role of adhesion molecule in vernal kera-toconjunctivitis. Sixth International Symposium of the Immunology and Immunopathology of the Eye. 1994;9.
  • Walsh CM, Mermord JJ, Hartnell A, Kay AB, Wardlaw AJ. Human eosinophil, but not neutrophil, adherence to IL-1 stimulated human umbilical vascular endothelial cells is a4131 (very late antigen-4) dependent. J Immunol. 1991;146: 3419–3423 .
  • Shoji J, Inada N, Takaura N, Sawa M. Histological study of allergic conjunctivitis. Jpn J Ophthalmol 1995;99:129–134.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.